Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study.
Blood Cancer Journal.
Times cited: 3
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
New England Journal of Medicine.
Times cited: 551
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: Molecular basis for antitumor activity and drug resistance of dasatinib.
Times cited: 43